Furthermore, based on the supplementary data, TAO activated up regulation of TG secretory genes, ApoB100 and ApoC3, and down regulation of TG intake genes, CD36 and FABP1. These results documented protective function of TAO for NAFLD in hepatocytes. The gene discussed is FABP1; the disease is metabolic dysfunction-associated steatotic liver disease.